Journey of AI-Powered Medical Solution for Brain Disease Diagnosis & Prognosis test
Journey of AI-Powered Medical Solution for Brain Disease Diagnosis & Prognosis test
As needs for accurate and efficient interpretation of medical imaging continue to rise, many hospitals and healthcare systems have employed AI-powered quantification technologies. During this webinar, neuroimage research leaders will discuss how to work with NEUROPHET products for both scientific research and clinical practice. Join the session to learn how AI-powered solutions, services, and real-time report augment your existing neuroimaging environment to provide fruitful source to improve your diagnostic and prognostic accuracy and efficiency.
Benefits of registering:
Free introductory session for NEUROPHET software.
Free extra-credits for brain MRI segmentation webservices 'Neurophet SegPlus'.
One Starbucks gift card for the first 50 registration and confirmed participants via email.
Join the conversation on Thursday 21st October at 11:00am (BST) to hear from out panel of experts discussing how AI-powered solutions are being used for brain disease diagnosis and prognosis.
Panel of speakers include:
Dr. Donghyeon Kim
Chief Technology Officer, Co-Founder NEUROPHET
Dr. Kim did his PhD at GIST, he has been worked over 10 years in neuroimaging research. He is in charge of development of all the technologies developed at NUEROPHET.
Dr. Regina EY Kim
Senior Researcher NEUROPHET
Dr. Kim has previously worked with large-scale clinical MRI data from the PREDICT-HD, KIDs-HD, and KoGES studies. Dr. Kim joined NEUROPHET in 2020 and now in charge of several scientific research related to neuroimaging.
Dr. Sungmin Wang
Clinical Professor, Department of Psychiatry THE CATHOLIC UNIV. OF KOREA YEOUIDO, ST. MARY'S HOSPITAL.
Director of Dementia Prevention Research Group, Korean Society of Geriatric Psychiatry
Research field: Geriatric Psychiatry, Anxiety and Depressive Disorders, bio psychiatry.
